These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26823025)

  • 1. Altitude and arteriolar hyalinosis after kidney transplantation.
    Cippà PE; Grebe SO; Fehr T; Wüthrich RP; Mueller TF
    Nephrology (Carlton); 2016 Sep; 21(9):782-4. PubMed ID: 26823025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
    Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
    Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular Arteriolar Hyalinosis as Histopathologic Hallmark of Calcineurin Inhibitor Nephrotoxicity: Does It Always Have the Same Meaning?
    Vázquez LC; González AP; Juega J; Hernández-Gallego A; López D; Cañas L; Bancu I; Bonet J; Lauzurica R
    Transplant Proc; 2015 Oct; 47(8):2357-60. PubMed ID: 26518926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance.
    Bröcker V; Schubert V; Scheffner I; Schwarz A; Hiss M; Becker JU; Scherer R; Haller H; Kreipe HH; Mengel M; Gwinner W
    Am J Pathol; 2012 May; 180(5):1852-62. PubMed ID: 22464889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of primary diabetic nephropathy on arteriolar hyalinosis lesions in patients following kidney transplantation.
    Yamakawa T; Kobayashi A; Yamamoto I; Kawaguchi T; Imasawa T; Aoyama H; Akutsu N; Maruyama M; Saigo K; Yokoo T; Kitamura H
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():70-75. PubMed ID: 29968417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.
    Singh L; Singh G; Sharma A; Sinha A; Bagga A; Dinda AK
    Hum Pathol; 2015 Jan; 46(1):34-9. PubMed ID: 25449629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.
    Kubal C; Cockwell P; Gunson B; Jesky M; Hanvesakul R; Dronavalli V; Bonser RS; Neil D
    Transplantation; 2012 Feb; 93(4):406-11. PubMed ID: 22217532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression.
    Einecke G; Reeve J; Halloran PF
    Am J Transplant; 2018 Apr; 18(4):821-831. PubMed ID: 28985016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.
    Snanoudj R; Royal V; Elie C; Rabant M; Girardin C; Morelon E; Kreis H; Fournet JC; Noël LH; Legendre C
    Am J Transplant; 2011 Dec; 11(12):2635-46. PubMed ID: 21883915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Chapman JR; Allen RD
    Transplantation; 2004 Aug; 78(4):557-65. PubMed ID: 15446315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cell transforming growth factor-β receptor activation causes tacrolimus-induced renal arteriolar hyalinosis.
    Chiasson VL; Jones KA; Kopriva SE; Mahajan A; Young KJ; Mitchell BM
    Kidney Int; 2012 Oct; 82(8):857-66. PubMed ID: 22495293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts.
    Miura M; Higashiyama H; Fukasawa Y; Itoh Y; Tamaki T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():58-60. PubMed ID: 26031588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual case of tacrolimus vascular toxicity after deceased donor renal transplantation.
    Sugitani A; Takahashi C; Naka T; Hisamitsu K; Yamamoto O; Taniguchi K; Kobayashi N; Kimura M; Yoshida H; Hamazoe R
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():60-2. PubMed ID: 27004749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of medial hyalinosis of small vessels in an allograft after discontinuation of cyclosporine.
    Bastani B; Amin K; Salinas-Madrigal L
    Ann Pharmacother; 2004; 38(7-8):1322-3. PubMed ID: 15173553
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity.
    Metalidis C; Lerut E; Naesens M; Kuypers DR
    Transplantation; 2011 May; 91(10):1098-102. PubMed ID: 21544031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
    Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
    Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of calcineurin inhibitors for kidney-transplant patients.
    Malvezzi P; Rostaing L
    Expert Opin Drug Saf; 2015 Oct; 14(10):1531-46. PubMed ID: 26329325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.